Connect
← Return to Gleason7(3+4) - treatment options recommendation
Discussion
Gleason7(3+4) - treatment options recommendation
Prostate Cancer | Last Active: 2 hours ago | Replies (251)Comment receiving replies
3+4 will not be candidate for active surveillance. This will be considered favorable intermediate risk. You should seek advice from medical professionals for treatment options
Replies to "3+4 will not be candidate for active surveillance. This will be considered favorable intermediate risk. You..."
@manojsmishra
While that might have been true many years ago that’s not true today. If someone only has one or two cores that are 3+4 and the percentage of four is only 5% or 10% then active surveillance makes a lot of sense. They could get a decipher score to find out what the chance of reoccurrence is, A low score would make active surveillance even more attractive.
Review this video and you will see what a doctor, with expertise in the field, feels about it
Excellent Fred Hutch doctor video: Dr. Claire de la Calle
Active Surveillance for Intermediate Risk Prostate Cancer w/ Dr. Claire de la Calle | Ep. 288
Connect
@manojsmishra
Why wouldn’t it be depending on the person’s circumstances.